Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs MRNA✓SelectedUSD · MRNASTX vs MRNA performance historyLatest closeAs of-3.09%11/13
Stock and ETF performance explorer

STX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+476.2%
MRNA return
-3.2%
Excess return
+479.4%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.1%-3.4%+0.4%-2.9%
7D+14.6%-12.1%+26.7%+15.2%
30D-26.0%-1.3%-24.7%-25.9%
3M-42.6%+250.9%-293.6%-47.1%
6M-35.3%+343.0%-378.3%-43.5%
YTD+92.5%+657.4%-565.0%+52.3%
1Y+102.4%+794.9%-692.5%+55.5%
3Y+673.8%+218.1%+455.7%+549.1%
All+476.2%-3.2%+479.4%+441.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling